SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-063823
Filing Date
2024-05-21
Accepted
2024-05-21 16:01:36
Documents
23
Period of Report
2024-05-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2414386d3_8k.htm   iXBRL 8-K 44211
2 EXHIBIT 4.1 tm2414386d3_ex4-1.htm EX-4.1 101688
3 EXHIBIT 4.2 tm2414386d3_ex4-2.htm EX-4.2 108576
4 EXHIBIT 5.1 tm2414386d3_ex5-1.htm EX-5.1 15370
5 EXHIBIT 5.2 tm2414386d3_ex5-2.htm EX-5.2 10889
6 EXHIBIT 10.1 tm2414386d3_ex10-1.htm EX-10.1 255572
7 EXHIBIT 10.2 tm2414386d3_ex10-2.htm EX-10.2 111804
11 GRAPHIC tm2414386d3_ex5-1img001.jpg GRAPHIC 3799
12 GRAPHIC tm2414386d3_ex5-2img001.jpg GRAPHIC 4408
13 GRAPHIC tm2414386d3_ex5-2img002.jpg GRAPHIC 4676
14 GRAPHIC tm2414386d3_ex5-2img003.jpg GRAPHIC 3070
  Complete submission text file 0001104659-24-063823.txt   1000878

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA seel-20240516.xsd EX-101.SCH 3015
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE seel-20240516_lab.xml EX-101.LAB 34240
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE seel-20240516_pre.xml EX-101.PRE 22359
26 EXTRACTED XBRL INSTANCE DOCUMENT tm2414386d3_8k_htm.xml XML 3676
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22245 | Film No.: 24969218
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)